Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

PathoCapital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$46M
Portfolio companies 3
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.50
Exits 2
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Biopharma
  • Health Care
  • Medical
  • Therapeutics
Summary

The venture was found in North America in United States. The main office of represented VC is situated in the Northbrook.

Among the various public portfolio startups of the fund, we may underline ReliefBand Technologies, Naurex, Aptinyx For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Digital Signage, Biotechnology.

The real fund results show that this VC is 3 percentage points less often commits exit comparing to other companies. Opposing the other organizations, this PathoCapital works on 4 percentage points more the average amount of lead investments. The important activity for fund was in 2015. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The top amount of exits for fund were in 2018.

The standard case for the fund is to invest in rounds with 9 partakers. Despite the PathoCapital, startups are often financed by Latterell Venture Partners, Adams Street Partners, Genesys Capital. The meaningful sponsors for the fund in investment in the same round are Adams Street Partners, Latterell Venture Partners, Goudy Park Capital. In the next rounds fund is usually obtained by Adams Street Partners, Savitr Capital, Latterell Venture Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of PathoCapital:
Typical Co-investors
PathoCapital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after PathoCapital:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aquarius 1 -
Bekaert Belgium, West-Vlaanderen, Zwevegem
EllisDon Canada, London, Ontario
GameWith Chiba, Japan, Minato
Garden State Life Sciences Venture Pennsylvania, Philadelphia, United States
HackerOne California, San Francisco, United States
Hilton Worldwide Mclean, United States, Virginia
Kyron Global Accelerator Bangalore, India, Karnataka
LR Group Herzlia B, Israel, Tel Aviv District
Nikko Antfactory -
Punchbowl Framingham, Massachusetts, United States
Ruixin Touzi China, Foshan, Guangdong
Satake Chemical Machinery Japan, Saitama Prefecture, Toda
ScaleIT Ventures Italy, Lombardy, Milan
Sinclair Broadcast Group Hunt Valley, Maryland, United States
Summit Pharmaceuticals International Chiyoda, Japan
Tin Fu Fund -
WirelessGate Japan, Tokyo
Yiguo Group Changning, China, Shanghai
Zheshang Securities China, Hangzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Aptinyx

Biopharma
Biotechnology
Health Care
Medical
$70M18 Dec 2017 Illinois, United States

Aptinyx

Biopharma
Biotechnology
Health Care
Medical
$65M10 May 2016 Illinois, United States

Naurex

Biopharma
Biotechnology
Therapeutics
$80M03 Dec 2014 Illinois, United States

Naurex

Biopharma
Biotechnology
Therapeutics
$38M17 Dec 2012 Illinois, United States

Naurex

Biopharma
Biotechnology
Therapeutics
$18M11 May 2011 Illinois, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent PathoCapital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 46M
Peak activity year 2017
Lead investments 0
Follow on index 0.50
Exits 2
Group Appearance index 0.83

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Aptinyx

Biopharma
Biotechnology
Health Care
Medical
$70M18 Dec 2017 Illinois, United States

Aptinyx

Biopharma
Biotechnology
Health Care
Medical
$65M10 May 2016 Illinois, United States

Naurex

Biopharma
Biotechnology
Therapeutics
$80M03 Dec 2014 Illinois, United States

Naurex

Biopharma
Biotechnology
Therapeutics
$38M17 Dec 2012 Illinois, United States

Naurex

Biopharma
Biotechnology
Therapeutics
$18M11 May 2011 Illinois, United States
Crunchbase icon

Content report

The following text will be sent to our editors: